NCT06488755View on ClinicalTrials.gov

SIM0718 Treatment of Asthma Clinical Study

PHASE3RecruitingINTERVENTIONAL
Enrollment

418

Participants

Timeline

Start Date

July 23, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

September 30, 2027

Conditions
Asthma; Eosinophilic
Interventions
DRUG

SIM0718 injection

"Dosage form: injection Specification: 300mg/2ml/bottle Dosage: A loading dose of 600 mg is injected subcutaneously on day 1, followed by 300 mg SIM0718 subcutaneously every two weeks.~Duration of medication: 52 weeks"

DRUG

SIM0718 injection of placebo

"Dosage form: injection Specification: 2ml/bottle Dosage: 4ml subcutaneously on day 1, followed by 2ml of placebo subcutaneously every two weeks.~Duration of medication: 52 weeks"

Trial Locations (1)

100000

RECRUITING

China Japan Friendship Hospital, Beijing

All Listed Sponsors
lead

Simcere Pharmaceutical Co., Ltd

OTHER